CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, announced today that it is taking orders for a new product that represents a significant advancement for synthetic biology tools. gBlocks Gene Fragments are double-stranded, sequence-verified genomic blocks up to 500 base pairs. Their high sequence fidelity and rapid delivery time makes […]
CARLSBAD, Calif.– Life Technologies Corporation today announced that Alan B. Sachs, M.D., Ph.D., former Vice President, Exploratory and Translational Sciences for Merck Research Laboratories, has joined the company as Head of Global Research and Development. Sachs brings more than 20 years of experience as a research scientist and a leader in developing innovative scientific platforms. […]
DES MOINES, Iowa, and Bothell, Wash., DuPont and OligoCo have entered into a collaboration to develop new technology that could enable the intense use of synthetic biology to help feed a growing global population. The efficient production of long, high-quality DNA segments known as oligonucleotides is essential to reliably transcribe genetic information into full length […]
The Tankyrase 1 Activity Assay from AMSBIO are highly sensitive screening kits for the identification of Tankyrase 1 inhibitors in an in vitro system. These new kits are the latest addition to the comprehensive range of high performance PARP assay kits, enzymes & antibodies available from AMSBIO to assist scientists with their DNA damage research. […]
Listeriosis is a serious infection caused by the bacterium Listeria monocytogenes. This infection is contracted by eating contaminated food. The infection can lead to miscarriage, stillbirth and meningitis. An outbreak in 2011 involving contaminated cantaloupes lead to 30 deaths. ViroStat has recently released a new set of monoclonal antibodies to Listeria. Several of these are […]
NEW YORK – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding. Addtech Life Science is a business area in the Addtech Group. BioNordika Holding is the parent company of the BioNordika Group, which markets reagents and instruments for biomedical research, primarily to the pharmaceutical industry and public institutions. BioNordika Group has […]
Basel, Switzerland – Rolf Soiron, Chairman of the Board of Lonza, commenting on today’s announcement, said:“With the acquisition of Arch in 2011 Lonza achieved another step in its transformation towards a global Life Science company. This continuous change characterized the past years and Stefan Borgas has led this process as Lonza’s CEO. The Board of […]
CHARLOTTESVILLE, Va.– ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced that it has signed an OEM agreement with Saudi Diagnostics Limited (SDL) for ZyGEM’s DNA and RNA extraction kits. SDL was established by the King Faisal Specialist Hospital & Research Centre (KFSH&RC) […]
Worthington Biochemical’s updated 2012 Tissue Dissociation Guide is now available to assist researchers with selecting enzymes, developing and optimizing protocols and better understanding the process of enzymatic primary cell isolation and tissue dissociation. The guide also discusses the enzymes most commonly used, their handling and specificity, and includes hundreds of new detailed cell and species-specific […]
BOTHELL, Wash. — BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells, tissues, and organs, today announced that three additional key opinion leaders in the biobanking, drug discovery, and regenerative medicine markets have joined the Company’s Scientific Advisory Board (SAB). The new members […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
